Aligos Therapeutics Inc. (ALGS)
NASDAQ: ALGS
· Real-Time Price · USD
9.79
0.43 (4.59%)
At close: Sep 26, 2025, 3:59 PM
9.51
-2.86%
After-hours: Sep 26, 2025, 06:02 PM EDT
Aligos Therapeutics Revenue
Aligos Therapeutics reported an annual revenue of $3.94M, reflecting a -74.6% growth. For the quarter ending June 30, 2025, Aligos Therapeutics generated $965K in revenue.
Revenue (ttm)
3.94M
Revenue Growth
-74.6%
Price / Sales Ratio
63.27
Revenue / Employee
56.36K
Employees
70
Market Cap
60.22M
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 3.94M | -74.60% |
| Dec 31, 2023 | 15.53M | +11.66% |
| Dec 31, 2022 | 13.91M | +219.04% |
| Dec 31, 2021 | 4.36M | +Infinity% |
| Dec 31, 2020 | 0 | n/a |
| Dec 31, 2019 | 0 | n/a |
| Dec 31, 2018 | 0 | n/a |